Director of Phasebio Pharmaceuticals Inc (NASDAQ:PHAS), Thorp Clay, buys 3,000 shares worth $11,010
According to Phasebio Pharmaceuticals Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 24 04:04 PM, company Director, Thorp Clay disclosed buying 3,000 shares at a cost of $3.67. At the time of this transaction (Nov 23), this trade was worth $11,010 in total. As of Nov 23, Thorp Clay now owns 20,943 shares in total worth about $74,766.51.
For the last few recent trades made by Phasebio Pharmaceuticals Inc (NASDAQ:PHAS) Director, Thorp Clay, we have the following information:
- SEC Form 4 filing: Nov 24: Bought 2,000 shares at the rate of $3.50 per share. Total worth of this trade was $7,000. Total number of shares owned as of Nov 24 were 22,943
Posted by
George Daniels
on Tuesday November 24 2020, 7:16 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
